Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: FDA News
Get the latest updates from Business Wire Health: FDA News directly as they happen.
Follow now 106 followers
Latest posts
Last updated about 6 hours ago
Guardant Health und James Van Der Beek schließen sich zusammen, um das Bewusstsein für neue Fortschritte bei der Darmkrebsvorsorge für Erwachsene ab 45 Jahren zu schärfen
about 6 hours ago
PALO ALTO, Kalifornien--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im...
Resumen: Guardant Health y James Van Der Beek se asocian para generar conciencia sobre los nuevos avances en la detección del cáncer colorrectal en los adultos mayores de 45 años
about 6 hours ago
PALO ALTO, California--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), una empresa líder en...
Riassunto: Guardant Health e James Van Der Beek si alleano per sensibilizzare il pubblico sui nuovi progressi nello screening del tumore del colon-retto per gli adulti di età superiore ai 45 anni
about 6 hours ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), società di spicco nell'oncologia...
Guardant Health et James Van Der Beek s’associent pour sensibiliser les adultes de 45 ans et plus aux dernières avancées en matière de dépistage du cancer colorectal
about 6 hours ago
PALO ALTO, Califonie--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq : GH), un chef de...
Samenvatting: Guardant Health en James Van Der Beek bundelen krachten om bewustzijn te creëren over nieuwe ontwikkelingen in screening op colorectale kanker voor volwassenen van 45 jaar en ouder
about 6 hours ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), een toonaangevend bedrijf in...
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
about 12 hours ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology...
Felycin®-CA1 (Sirolimus Delayed-Release Tablets) is the First and Only Drug FDA Approved for the Management of Ventricular Hypertrophy in Cats with Subclinical Hypertrophic Cardiomyopathy (HCM), A Condition Affecting as Many as One in Seven Cats
about 12 hours ago
SHAWNEE, Kan.--(BUSINESS WIRE)--PBI-Gordon Companies, Inc. the parent company of TriviumVet, which holds...
Actio Biosciences Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy
about 19 hours ago
SAN DIEGO--(BUSINESS WIRE)--Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach...
Stallergenes Greer Announces Palforzia® Featured on “The Balancing Act” Airing on Lifetime TV
about 20 hours ago
LENOIR, N.C.--(BUSINESS WIRE)--Stallergenes Greer announces Palforzia® featured on ''The Balancing Act'' airing...
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
about 20 hours ago
PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision...
Cardiosense Receives FDA 510(k) Clearance for the CardioTag™ Device, Paving the Way for Advanced Cardiac Function Monitoring
about 20 hours ago
CHICAGO--(BUSINESS WIRE)--Cardiosense, a medical AI company transforming cardiovascular disease management, today announced...
Neuvivo Reaches Alignment with FDA on an Approval Pathway for NP001 to Treat ALS and Announces the Appointment of Biopharmaceutical Expert Dr. John Curnutte to Its Board of Directors
about 20 hours ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Neuvivo, Inc., a late-stage biopharmaceutical company developing treatments for...